"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","25/37","481/2914",4.17141404023325e-12,1.67273703013353e-09,1.14604112052724e-09,"AKT2/CSNK2A1/GSK3B/JUN/MAPK1/MAPK14/MAPK3/MAX/PRKACA/SMAD3/TP53/YAP1/VDR/MYB/FOS/FOXO1/FOXO3/HNF4A/JUNB/MEF2C/MYC/STAT1/TWIST1/TCF7L2/TEAD1",25
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","25/37","499/2914",9.82656245613694e-12,1.97022577245546e-09,1.3498593689746e-09,"AKT2/CSNK2A1/GSK3B/JUN/MAPK1/MAPK14/MAPK3/MAX/PRKACA/SMAD3/TP53/YAP1/VDR/MYB/FOS/FOXO1/FOXO3/HNF4A/JUNB/MEF2C/MYC/STAT1/TWIST1/TCF7L2/TEAD1",25
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","8/37","30/2914",1.45386243799087e-09,1.94332945878113e-07,1.33143191689691e-07,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","5/37","10/2914",6.01188014343971e-08,6.02690984379831e-06,4.1292124143099e-06,"JUN/MAPK1/MAPK14/MAPK3/FOS",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","17/37","332/2914",1.15694951565835e-07,9.27873511557996e-06,6.35713312814377e-06,"JUN/MAPK1/MAPK14/MAPK3/PRKACA/RPS6KA5/SMAD3/TP53/ATF1/FOS/FOXO1/FOXO3/JUNB/MEF2C/MYC/STAT1/TWIST1",17
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","18/37","397/2914",2.66987762193506e-07,1.78436821065993e-05,1.22252291109658e-05,"AKT2/CSNK2A1/GSK3B/JUN/MAPK1/MAPK14/MAPK3/PRKACA/RPS6KA4/RPS6KA5/SMAD3/TCF4/MYB/FOXO1/FOXO3/HNF4A/MEF2C/MYC",18
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","6/37","24/2914",3.13490382028739e-07,1.79585204562178e-05,1.23039082269926e-05,"MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/MEF2C",6
"R-HSA-450294","R-HSA-450294","MAP kinase activation","8/37","60/2914",4.8555707983525e-07,2.43385486267419e-05,1.66750523469737e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","8/37","64/2914",8.10257260151433e-07,3.61014623689694e-05,2.47341689940964e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","7/37","53/2914",2.97063685881205e-06,0.000116695239335829,7.99513255457445e-05,"SMAD3/TP53/YAP1/FOXO3/MYC/TCF7L2/TEAD1",7
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","8/37","78/2914",3.78313743482738e-06,0.000116695239335829,7.99513255457445e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","8/37","78/2914",3.78313743482738e-06,0.000116695239335829,7.99513255457445e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","8/37","78/2914",3.78313743482738e-06,0.000116695239335829,7.99513255457445e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","5/37","21/2914",4.3867872300095e-06,0.000125650119945272,8.60865764686074e-05,"MAPK1/MAPK14/MAPK3/RPS6KA5/MEF2C",5
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","9/37","108/2914",4.9341280600427e-06,0.000131905690138475,9.03724507839399e-05,"AKT2/FOXA1/JUN/MAPK1/MAPK3/MYB/FOS/FOXO3/MYC",9
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","8/37","83/2914",6.08308304843837e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","8/37","84/2914",6.66291313195131e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","8/37","84/2914",6.66291313195131e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","8/37","86/2914",7.96422439518696e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","8/37","86/2914",7.96422439518696e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","8/37","86/2914",7.96422439518696e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","8/37","87/2914",8.69177002881826e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","8/37","87/2914",8.69177002881826e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","8/37","87/2914",8.69177002881826e-06,0.000137467762160308,9.41831891950133e-05,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","7/37","62/2914",8.72935414967875e-06,0.000137467762160308,9.41831891950133e-05,"AKT2/GSK3B/MAPK1/MAPK3/YAP1/STAT1/TWIST1",7
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","5/37","24/2914",8.91312173607981e-06,0.000137467762160308,9.41831891950133e-05,"AKT2/MAPK1/MAPK3/FOS/FOXO3",5
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","8/37","90/2914",1.12214256622051e-05,0.000160706846090866,0.000110104966084043,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","8/37","90/2914",1.12214256622051e-05,0.000160706846090866,0.000110104966084043,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","6/37","44/2914",1.36767573053833e-05,0.00018911654067099,0.00012956927973521,"JUN/MAPK1/MAPK14/MAPK3/TP53/FOS",6
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","8/37","94/2914",1.55413253580687e-05,0.000207735715619518,0.000142325821700208,"TP53/FOS/FOXO1/FOXO3/JUNB/MYC/STAT1/TWIST1",8
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","9/37","136/2914",3.28824800078813e-05,0.000425350789779368,0.000291420281224347,"AKT2/FOXA1/JUN/MAPK1/MAPK3/MYB/FOS/FOXO3/MYC",9
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","8/37","110/2914",4.94758383938759e-05,0.000619994099873257,0.000424776112526369,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","5/37","34/2914",5.32144036367155e-05,0.000646635632070392,0.000443029006353517,"JUN/PRKACA/FOXO1/FOXO3/MYC",5
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","6/37","59/2914",7.6022344348743e-05,0.000896616473054292,0.000614298200465075,"AKT2/CSNK2A1/JUN/MAPK1/MAPK3/TP53",6
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","10/37","201/2914",0.000130791810682074,0.0014985004595289,0.00102666654400064,"AKT2/CSNK2A1/GSK3B/JUN/MAPK1/MAPK3/PRKACA/TP53/FOXO1/FOXO3",10
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","8/37","127/2914",0.000138673790625764,0.00154467194558143,0.00105829998109136,"JUN/MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/FOS/MEF2C",8
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/37","23/2914",0.000164075662202482,0.00177822542008635,0.00121831430540107,"MAPK1/MAPK3/TP53/ETS1",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","7/37","99/2914",0.00018821218336472,0.00198613382971717,0.00136075844482526,"JUN/MAPK1/MAPK14/MAPK3/TP53/ETS1/FOS",7
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/37","24/2914",0.000195108170295762,0.00200364693592124,0.00137275718670545,"AKT2/GSK3B/FOXO1/FOXO3",4
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","6/37","70/2914",0.000199865031014587,0.00200364693592124,0.00137275718670545,"MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/MEF2C",6
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","9/37","172/2914",0.000208624148680569,0.00204044594197337,0.0013979692633024,"AKT2/CSNK2A1/GSK3B/JUN/MAPK1/MAPK3/TP53/FOXO1/FOXO3",9
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/37","11/2914",0.000290068147865854,0.00270505412312111,0.00185331178930203,"AKT2/FOXO1/HNF4A",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/37","11/2914",0.000290068147865854,0.00270505412312111,0.00185331178930203,"AKT2/FOXO1/FOXO3",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","5/37","49/2914",0.000317599920170209,0.00289449018155122,0.00198309998001015,"FOXA1/JUN/MYB/FOS/MYC",5
"R-HSA-373760","R-HSA-373760","L1CAM interactions","5/37","53/2914",0.000460662445012314,0.0040185597006446,0.0027532329226099,"CSNK2A1/MAPK1/MAPK3/RPS6KA4/RPS6KA5",5
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","9/37","191/2914",0.000460981910797137,0.0040185597006446,0.0027532329226099,"AKT2/CSNK2A1/GSK3B/MAPK1/MAPK3/MAX/PRKACA/TP53/MYC",9
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","4/37","30/2914",0.000476481161862035,0.00406529672141864,0.00278525382409834,"JUN/MAPK1/MAPK3/FOS",4
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/37","32/2914",0.000613964092370855,0.00510077069470206,0.00349468736400378,"JUN/MAPK1/MAPK3/TP53",4
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/37","14/2914",0.000623286194614466,0.00510077069470206,0.00349468736400378,"SMAD3/FOXO1/FOXO3",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","6/37","89/2914",0.000743175228050612,0.00596026532896591,0.00408355230570968,"MAPK1/MAPK14/MAPK3/RPS6KA5/ATF1/MEF2C",6
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/37","16/2914",0.000942237864079443,0.00740857614697758,0.00507583245665087,"MAPK1/MAPK14/MAPK3",3
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","5/37","63/2914",0.00102900215187277,0.00793518967117267,0.00543663080240469,"AKT2/MAPK1/MAPK3/FOS/FOXO3",5
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","10/37","268/2914",0.00135112228992338,0.0102226422313071,0.00700383153267133,"AKT2/GSK3B/MAPK1/MAPK3/SMAD3/FOXO1/FOXO3/MYC/STAT1/TCF7L2",10
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/37","19/2914",0.00158812843704115,0.0115789000591546,0.00793304348455006,"MAPK1/MAPK3/YAP1",3
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/37","19/2914",0.00158812843704115,0.0115789000591546,0.00793304348455006,"SMAD3/FOXO1/FOXO3",3
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","3/37","20/2914",0.00185210564875326,0.013029725704387,0.00892704661725948,"MAPK1/RPS6KA4/RPS6KA5",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/37","20/2914",0.00185210564875326,0.013029725704387,0.00892704661725948,"CSNK2A1/MAPK1/MAPK3",3
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","8/37","187/2914",0.00190366053733744,0.0131615150943502,0.00901733938738785,"GSK3B/JUN/MAPK1/MAPK14/MAPK3/TP53/ETS1/FOS",8
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","8/37","189/2914",0.00203830970723928,0.0138535964847958,0.00949150461354955,"GSK3B/JUN/MAPK1/MAPK14/MAPK3/TP53/ETS1/FOS",8
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/37","45/2914",0.00226070612302692,0.0151090525888966,0.0103516543528075,"JUN/MAPK1/MAPK3/FOS",4
"R-HSA-525793","R-HSA-525793","Myogenesis","3/37","22/2914",0.0024585764524243,0.0161621173347893,0.0110731398461215,"MAPK14/TCF4/MEF2C",3
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","9/37","249/2914",0.00309379223644789,0.0187247660994608,0.0128288855544278,"AKT2/CSNK2A1/GSK3B/MAPK1/MAPK3/MAX/PRKACA/TP53/MYC",9
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/37","49/2914",0.00310029944894169,0.0187247660994608,0.0128288855544278,"AKT2/MAPK1/MAPK3/TP53",4
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","4/37","49/2914",0.00310029944894169,0.0187247660994608,0.0128288855544278,"AKT2/SMAD3/FOXO1/FOXO3",4
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/37","24/2914",0.00317527205676642,0.0187247660994608,0.0128288855544278,"AKT2/FOXO1/HNF4A",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","3/37","24/2914",0.00317527205676642,0.0187247660994608,0.0128288855544278,"SMAD3/JUNB/MYC",3
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","3/37","24/2914",0.00317527205676642,0.0187247660994608,0.0128288855544278,"MAPK1/MAPK3/YAP1",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/37","24/2914",0.00317527205676642,0.0187247660994608,0.0128288855544278,"MAPK1/MAPK3/STAT1",3
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","3/37","26/2914",0.00400826678308974,0.0232944200002752,0.0159596892507463,"GSK3B/STAT1/TWIST1",3
"R-HSA-1643685","R-HSA-1643685","Disease","12/37","443/2914",0.00647176277855289,0.0354072988811426,0.0242585772620507,"AKT2/GSK3B/JUN/MAPK1/MAPK3/PRKACA/SMAD3/FOXO1/FOXO3/MYC/STAT1/TCF7L2",12
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/37","10/2914",0.00662231275831844,0.0354072988811426,0.0242585772620507,"MAPK1/MAPK3",2
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","2/37","10/2914",0.00662231275831844,0.0354072988811426,0.0242585772620507,"AKT2/TP53",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/37","10/2914",0.00662231275831844,0.0354072988811426,0.0242585772620507,"MAPK1/MAPK3",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/37","10/2914",0.00662231275831844,0.0354072988811426,0.0242585772620507,"FOXO1/FOXO3",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/37","10/2914",0.00662231275831844,0.0354072988811426,0.0242585772620507,"MAPK1/MAPK3",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/37","32/2914",0.00725665461903833,0.0377911493796671,0.0258918230426385,"GSK3B/MAPK1/MAPK3",3
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/37","32/2914",0.00725665461903833,0.0377911493796671,0.0258918230426385,"MAPK1/MAPK3/RPS6KA5",3
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/37","33/2914",0.00791308704859937,0.0406813834165173,0.0278720070132852,"MAPK1/MAPK14/MAPK3",3
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/37","11/2914",0.00802947822730789,0.0407572249259552,0.0279239682521967,"MAX/MYC",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/37","34/2914",0.00860362330045736,0.0431256617935425,0.0295466537028865,"JUN/TP53/FOS",3
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","10/37","347/2914",0.00907782504898883,0.0445702091144388,0.0305363553717509,"AKT2/MAPK1/MAPK14/MAPK3/PRKACA/RPS6KA5/YAP1/ATF1/MEF2C/STAT1",10
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","5/37","104/2914",0.00922955207427292,0.0445702091144388,0.0305363553717509,"JUN/SMAD3/TP53/MYC/STAT1",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/37","12/2914",0.00955869821406916,0.0445702091144388,0.0305363553717509,"MAPK1/MAPK3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/37","12/2914",0.00955869821406916,0.0445702091144388,0.0305363553717509,"MAPK1/MAPK3",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/37","12/2914",0.00955869821406916,0.0445702091144388,0.0305363553717509,"MAPK1/MAPK3",2
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","2/37","12/2914",0.00955869821406916,0.0445702091144388,0.0305363553717509,"YAP1/TEAD1",2
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/37","36/2914",0.0100885495622339,0.0465000962581124,0.031858577564949,"SMAD3/JUNB/MYC",3
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","5/37","108/2914",0.010783094335905,0.0491366003261124,0.0336649237042009,"AKT2/CSNK2A1/GSK3B/MYC/TCF7L2",5
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/37","13/2914",0.0112068181446667,0.0493838909451796,0.0338343497485021,"MAPK1/MAPK3",2
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","2/37","13/2914",0.0112068181446667,0.0493838909451796,0.0338343497485021,"AKT2/GSK3B",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/37","13/2914",0.0112068181446667,0.0493838909451796,0.0338343497485021,"FOXO1/FOXO3",2
"R-HSA-69242","R-HSA-69242","S Phase","4/37","71/2914",0.0116513351724044,0.050509722723658,0.0346056900666091,"AKT2/GSK3B/MAX/MYC",4
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","3/37","38/2914",0.0117142249708234,0.050509722723658,0.0346056900666091,"MAPK14/GABPA/MEF2C",3
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","7/37","202/2914",0.0119564169508535,0.0510055659286409,0.0349454067656524,"JUN/MAPK1/MAPK3/PRKACA/FOXO1/FOXO3/MYC",7
"R-HSA-422475","R-HSA-422475","Axon guidance","8/37","254/2914",0.012367414282742,0.0522035066039954,0.0357661510005061,"CSNK2A1/GSK3B/MAPK1/MAPK14/MAPK3/PRKACA/RPS6KA4/RPS6KA5",8
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/37","39/2914",0.0125805919508942,0.0525501809615478,0.0360036677542039,"AKT2/MAX/MYC",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/37","14/2914",0.0129707401363421,0.0530741509660528,0.0363626549472103,"MAPK1/MAPK3",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/37","14/2914",0.0129707401363421,0.0530741509660528,0.0363626549472103,"AKT2/TP53",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/37","40/2914",0.0134829900239835,0.0546129191880542,0.0374169101144039,"AKT2/MAX/MYC",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/37","15/2914",0.0148474221280158,0.0583707477777875,0.0399915085181849,"SMAD3/FOXO3",2
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","2/37","15/2914",0.0148474221280158,0.0583707477777875,0.0399915085181849,"JUN/FOXO3",2
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","2/37","15/2914",0.0148474221280158,0.0583707477777875,0.0399915085181849,"JUN/FOXO3",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","5/37","119/2914",0.0159679753900326,0.0621665838000297,0.0425921469269137,"ARNTL/CSNK2A1/PRKACA/CLOCK/VDR",5
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/37","16/2914",0.0168338770228638,0.0649075450593116,0.0444700597466342,"MAPK1/MAPK3",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","4/37","80/2914",0.0174861356559225,0.0667803847430944,0.0457531970545941,"MAPK14/PRKACA/GABPA/MEF2C",4
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","3/37","47/2914",0.0208245587824102,0.0784342146742212,0.0537375771885332,"MAPK1/MAPK3/PRKACA",3
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","2/37","18/2914",0.0211244268948027,0.0784342146742212,0.0537375771885332,"GSK3B/PRKACA",2
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/37","18/2914",0.0211244268948027,0.0784342146742212,0.0537375771885332,"MAPK1/MAPK3",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","4/37","87/2914",0.0231056157659677,0.0816743373427083,0.0559574801061737,"JUN/MAPK1/MAPK3/FOS",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/37","49/2914",0.0232552996164119,0.0816743373427083,0.0559574801061737,"GSK3B/MAPK1/MAPK3",3
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","3/37","49/2914",0.0232552996164119,0.0816743373427083,0.0559574801061737,"MAPK1/MAPK3/PRKACA",3
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","2/37","19/2914",0.023422814948657,0.0816743373427083,0.0559574801061737,"ARNTL/CLOCK",2
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","2/37","19/2914",0.023422814948657,0.0816743373427083,0.0559574801061737,"MAX/MYC",2
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","2/37","19/2914",0.023422814948657,0.0816743373427083,0.0559574801061737,"GSK3B/PRKACA",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/37","19/2914",0.023422814948657,0.0816743373427083,0.0559574801061737,"PRKACA/RPS6KA5",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/37","52/2914",0.0271806946833973,0.0923682929495113,0.0632842222334229,"ARNTL/CLOCK/MEF2C",3
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/37","52/2914",0.0271806946833973,0.0923682929495113,0.0632842222334229,"AKT2/MAPK1/MAPK3",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/37","52/2914",0.0271806946833973,0.0923682929495113,0.0632842222334229,"AKT2/MAPK1/MAPK3",3
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","4/37","95/2914",0.0307517090238225,0.102395100843415,0.070153881927107,"AKT2/CSNK2A1/MAPK14/TP53",4
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/37","22/2914",0.0308972748180879,0.102395100843415,0.070153881927107,"MYC/TCF7L2",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/37","22/2914",0.0308972748180879,0.102395100843415,0.070153881927107,"MAPK1/MAPK3",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","4/37","97/2914",0.0328727564800869,0.106847225580997,0.0732041629521988,"AKT2/GSK3B/FOXO1/FOXO3",4
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/37","56/2914",0.03293495099129,0.106847225580997,0.0732041629521988,"CSNK2A1/MAPK14/TP53",3
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","6/37","194/2914",0.0331037250540576,0.106847225580997,0.0732041629521988,"AKT2/CSNK2A1/JUN/MAPK14/TP53/FOS",6
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/37","23/2914",0.0335729436987671,0.106847225580997,0.0732041629521988,"MAPK1/MAPK3",2
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/37","23/2914",0.0335729436987671,0.106847225580997,0.0732041629521988,"JUN/TP53",2
"R-HSA-109581","R-HSA-109581","Apoptosis","4/37","101/2914",0.0373700779728427,0.117995285567795,0.0808420252872933,"AKT2/MAPK1/MAPK3/TP53",4
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/37","25/2914",0.0391850198164328,0.120236904811005,0.0823778242700414,"MAPK1/MAPK3",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/37","25/2914",0.0391850198164328,0.120236904811005,0.0823778242700414,"MAPK1/MAPK3",2
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","2/37","25/2914",0.0391850198164328,0.120236904811005,0.0823778242700414,"AKT2/CSNK2A1",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/37","60/2914",0.0392793878559642,0.120236904811005,0.0823778242700414,"AKT2/MAX/MYC",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","4/37","103/2914",0.0397470784813321,0.120746806598592,0.0827271729156911,"AKT2/MAPK1/MAPK3/TP53",4
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/37","26/2914",0.0421164159025447,0.126314932952161,0.0865420593267204,"MAPK1/PRKACA",2
"R-HSA-68886","R-HSA-68886","M Phase","4/37","105/2914",0.0422099775949866,0.126314932952161,0.0865420593267204,"CSNK2A1/MAPK1/MAPK3/PRKACA",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","3/37","62/2914",0.0426703651601359,0.126746788364552,0.0868379361153643,"PRKACA/TP53/MYB",3
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/37","63/2914",0.0444199605225526,0.130189758777853,0.0891968159627761,"SMAD3/JUNB/MYC",3
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/37","27/2914",0.045128120873121,0.130189758777853,0.0891968159627761,"MAPK1/MAPK3",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/37","27/2914",0.045128120873121,0.130189758777853,0.0891968159627761,"YAP1/MYB",2
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","2/37","27/2914",0.045128120873121,0.130189758777853,0.0891968159627761,"MYB/MYC",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/37","28/2914",0.0482177445116367,0.138109396779759,0.0946227918611818,"MAPK1/MAPK3",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/37","29/2914",0.0513829414497982,0.143087218898396,0.098033243555536,"AKT2/TP53",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/37","29/2914",0.0513829414497982,0.143087218898396,0.098033243555536,"JUN/TP53",2
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","2/37","29/2914",0.0513829414497982,0.143087218898396,0.098033243555536,"AKT2/TP53",2
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","2/37","29/2914",0.0513829414497982,0.143087218898396,0.098033243555536,"AKT2/TP53",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/37","30/2914",0.0546214104636513,0.150021819150165,0.10278434124739,"CSNK2A1/TP53",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/37","30/2914",0.0546214104636513,0.150021819150165,0.10278434124739,"MAPK1/MAPK3",2
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/37","31/2914",0.057930893779616,0.155907975876685,0.106817119579511,"AKT2/TCF7L2",2
"R-HSA-391251","R-HSA-391251","Protein folding","2/37","31/2914",0.057930893779616,0.155907975876685,0.106817119579511,"CSNK2A1/TP53",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/37","31/2914",0.057930893779616,0.155907975876685,0.106817119579511,"GSK3B/TCF7L2",2
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","2/37","32/2914",0.0613091763903211,0.161743287713939,0.110815062589154,"GABPA/MEF2C",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/37","32/2914",0.0613091763903211,0.161743287713939,0.110815062589154,"MAPK1/MAPK3",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/37","32/2914",0.0613091763903211,0.161743287713939,0.110815062589154,"MAPK1/MAPK3",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","5/37","172/2914",0.0636164443914857,0.166733295431279,0.114233862993999,"AKT2/CSNK2A1/GSK3B/MYC/TCF7L2",5
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","2/37","33/2914",0.0647540853801096,0.168612910632623,0.115521642407441,"MAPK1/MAPK3",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/37","34/2914",0.0682634892600879,0.172161378574184,0.117952801700648,"MAPK1/PRKACA",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/37","34/2914",0.0682634892600879,0.172161378574184,0.117952801700648,"MAPK1/PRKACA",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/37","34/2914",0.0682634892600879,0.172161378574184,0.117952801700648,"MAPK3/STAT1",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/37","34/2914",0.0682634892600879,0.172161378574184,0.117952801700648,"MAPK1/MAPK3",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/37","34/2914",0.0682634892600879,0.172161378574184,0.117952801700648,"MAPK1/MAPK3",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/37","35/2914",0.0718352973125952,0.177432451116515,0.121564167847251,"MAPK3/STAT1",2
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","2/37","35/2914",0.0718352973125952,0.177432451116515,0.121564167847251,"GSK3B/PRKACA",2
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/37","35/2914",0.0718352973125952,0.177432451116515,0.121564167847251,"AKT2/TP53",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","3/37","77/2914",0.0725658902321906,0.177432451116515,0.121564167847251,"MAPK1/MAPK3/PRKACA",3
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","3/37","77/2914",0.0725658902321906,0.177432451116515,0.121564167847251,"AKT2/MAX/MYC",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","2/37","37/2914",0.0791579630524869,0.190754838874392,0.130691725807104,"GSK3B/TCF7L2",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/37","37/2914",0.0791579630524869,0.190754838874392,0.130691725807104,"MAPK1/MAPK3",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/37","80/2914",0.0794415413766171,0.190754838874392,0.130691725807104,"SMAD3/TP53/MYC",3
"R-HSA-168249","R-HSA-168249","Innate Immune System","9/37","428/2914",0.081899081675419,0.195485308046685,0.133932708754915,"JUN/MAPK1/MAPK14/MAPK3/PRKACA/RPS6KA5/ATF1/FOS/MEF2C",9
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/37","38/2914",0.0829048373903571,0.196715028364102,0.134775226153119,"MAPK1/MAPK3",2
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","3/37","85/2914",0.0915158262219474,0.215869684205888,0.14789864175807,"AKT2/MAPK14/PRKACA",3
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","3/37","86/2914",0.0940196753397583,0.217702737061053,0.149154519944704,"CSNK2A1/YAP1/MYB",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/37","86/2914",0.0940196753397583,0.217702737061053,0.149154519944704,"SMAD3/JUNB/MYC",3
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/37","41/2914",0.0944645292983122,0.217702737061053,0.149154519944704,"MAPK1/MAPK3",2
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","2/37","41/2914",0.0944645292983122,0.217702737061053,0.149154519944704,"PRKACA/MEF2C",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/37","42/2914",0.0984179178252643,0.221716769932196,0.151904651403867,"MAPK1/MAPK3",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/37","42/2914",0.0984179178252643,0.221716769932196,0.151904651403867,"MAPK1/MAPK3",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/37","42/2914",0.0984179178252643,0.221716769932196,0.151904651403867,"MAPK1/MAPK3",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/37","42/2914",0.0984179178252643,0.221716769932196,0.151904651403867,"MAPK1/MAPK3",2
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","3/37","88/2914",0.0991133804277274,0.222036120399546,0.152123447760287,"MAPK1/MAPK3/PRKACA",3
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/37","43/2914",0.102418376896366,0.228165384085794,0.156322785789191,"MAPK1/MAPK3",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","3/37","92/2914",0.109634026629975,0.24289085457801,0.16641163681549,"AKT2/MAPK14/PRKACA",3
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/37","46/2914",0.114684832542336,0.251303922674737,0.172175676120505,"VDR/HNF4A",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/37","46/2914",0.114684832542336,0.251303922674737,0.172175676120505,"MAPK1/MAPK3",2
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/37","47/2914",0.118856400265,0.254886761357906,0.174630383815234,"ARNTL/CLOCK",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/37","10/2914",0.120133660590135,0.254886761357906,0.174630383815234,"MAPK3",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/37","10/2914",0.120133660590135,0.254886761357906,0.174630383815234,"GSK3B",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/37","10/2914",0.120133660590135,0.254886761357906,0.174630383815234,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/37","10/2914",0.120133660590135,0.254886761357906,0.174630383815234,"STAT1",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/37","10/2914",0.120133660590135,0.254886761357906,0.174630383815234,"STAT1",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/37","48/2914",0.123066621145464,0.259735342522795,0.177952288747735,"ARNTL/CLOCK",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/37","49/2914",0.127313911423296,0.262538728606285,0.179872970642448,"MAPK1/MAPK3",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","3/37","99/2914",0.129048143085855,0.262538728606285,0.179872970642448,"AKT2/MAPK1/MAPK3",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"STAT1",1
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"AKT2",1
"R-HSA-163615","R-HSA-163615","PKA activation","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"PRKACA",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"TP53",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"TP53",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"TP53",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"GSK3B",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/37","11/2914",0.131344078826418,0.262538728606285,0.179872970642448,"STAT1",1
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/37","50/2914",0.131596719326342,0.262538728606285,0.179872970642448,"MAPK1/MAPK3",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"CSNK2A1",1
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"SMAD3",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"STAT1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"TCF7L2",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"PRKACA",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"PRKACA",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"PRKACA",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/37","12/2914",0.142415477063904,0.273246920108256,0.187209466198333,"PRKACA",1
"R-HSA-112316","R-HSA-112316","Neuronal System","3/37","105/2914",0.14661479009869,0.277252457423888,0.189953777103648,"MAPK1/MAPK3/PRKACA",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"PRKACA",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"MAPK14",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"GSK3B",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"GSK3B",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"GSK3B",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"GSK3B",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"GSK3B",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"GSK3B",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"TP53",1
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","1/37","13/2914",0.15334953197384,0.277252457423888,0.189953777103648,"AKT2",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/37","55/2914",0.153491385406741,0.277252457423888,0.189953777103648,"MAPK1/MAPK3",2
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","2/37","55/2914",0.153491385406741,0.277252457423888,0.189953777103648,"GSK3B/PRKACA",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/37","56/2914",0.157956438533239,0.284038259425242,0.194602928757024,"CSNK2A1/PRKACA",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"TCF7L2",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"GSK3B",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"GSK3B",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"GSK3B",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"GSK3B",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"GSK3B",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"GSK3B",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/37","14/2914",0.164147900576725,0.284949385849639,0.195227168150035,"STAT1",1
"R-HSA-109582","R-HSA-109582","Hemostasis","6/37","298/2914",0.170785138010511,0.289668183499311,0.198460154595932,"MAPK1/MAPK14/MAPK3/PRKACA/TP53/MYB",6
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/37","59/2914",0.171499418104472,0.289668183499311,0.198460154595932,"MAPK1/PRKACA",2
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"AKT2",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"YAP1",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"PRKACA",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"MAPK14",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"GSK3B",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"TP53",1
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"TP53",1
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","1/37","15/2914",0.174812220465919,0.289668183499311,0.198460154595932,"SMAD3",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","2/37","62/2914",0.185237392977631,0.299689468232033,0.205326030210161,"MAPK1/MAPK3",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/37","16/2914",0.185344110028789,0.299689468232033,0.205326030210161,"GSK3B",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/37","16/2914",0.185344110028789,0.299689468232033,0.205326030210161,"TP53",1
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","1/37","16/2914",0.185344110028789,0.299689468232033,0.205326030210161,"AKT2",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/37","16/2914",0.185344110028789,0.299689468232033,0.205326030210161,"CSNK2A1",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/37","16/2914",0.185344110028789,0.299689468232033,0.205326030210161,"TP53",1
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/37","17/2914",0.195745168665412,0.312724353126814,0.21425661153983,"PRKACA",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/37","17/2914",0.195745168665412,0.312724353126814,0.21425661153983,"MAPK14",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/37","17/2914",0.195745168665412,0.312724353126814,0.21425661153983,"SMAD3",1
"R-HSA-69275","R-HSA-69275","G2/M Transition","2/37","66/2914",0.203801995773519,0.322706280386519,0.221095522196828,"PRKACA/TP53",2
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/37","18/2914",0.20601697700486,0.322706280386519,0.221095522196828,"PRKACA",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/37","18/2914",0.20601697700486,0.322706280386519,0.221095522196828,"CSNK2A1",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/37","18/2914",0.20601697700486,0.322706280386519,0.221095522196828,"MAX",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/37","18/2914",0.20601697700486,0.322706280386519,0.221095522196828,"STAT1",1
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","3/37","124/2914",0.206828604215724,0.322717005021421,0.221102869958238,"SMAD3/TP53/MYC",3
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","2/37","68/2914",0.213170039989352,0.331322426495079,0.226998696194292,"PRKACA/TP53",2
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","1/37","19/2914",0.216161097119093,0.333386922864447,0.228413143109649,"AKT2",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/37","19/2914",0.216161097119093,0.333386922864447,0.228413143109649,"CSNK2A1",1
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/37","20/2914",0.226179072734497,0.339611284645306,0.232677635627838,"MAPK14",1
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","1/37","20/2914",0.226179072734497,0.339611284645306,0.232677635627838,"SMAD3",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/37","20/2914",0.226179072734497,0.339611284645306,0.232677635627838,"PRKACA",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/37","20/2914",0.226179072734497,0.339611284645306,0.232677635627838,"PRKACA",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/37","20/2914",0.226179072734497,0.339611284645306,0.232677635627838,"PRKACA",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/37","20/2914",0.226179072734497,0.339611284645306,0.232677635627838,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/37","20/2914",0.226179072734497,0.339611284645306,0.232677635627838,"MAPK3",1
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","3/37","130/2914",0.226972130386389,0.339611284645306,0.232677635627838,"MAPK1/MAPK14/MAPK3",3
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/37","72/2914",0.232035739473011,0.345897143229284,0.236984261406597,"PRKACA/RPS6KA5",2
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/37","21/2914",0.23607242944107,0.348033250756872,0.238447771223372,"AKT2",1
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","1/37","21/2914",0.23607242944107,0.348033250756872,0.238447771223372,"AKT2",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/37","21/2914",0.23607242944107,0.348033250756872,0.238447771223372,"MAPK14",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/37","22/2914",0.245842674899308,0.353343772883951,0.242086165435651,"PRKACA",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/37","22/2914",0.245842674899308,0.353343772883951,0.242086165435651,"SMAD3",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/37","22/2914",0.245842674899308,0.353343772883951,0.242086165435651,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/37","22/2914",0.245842674899308,0.353343772883951,0.242086165435651,"PRKACA",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/37","22/2914",0.245842674899308,0.353343772883951,0.242086165435651,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/37","22/2914",0.245842674899308,0.353343772883951,0.242086165435651,"TP53",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/37","22/2914",0.245842674899308,0.353343772883951,0.242086165435651,"PRKACA",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/37","23/2914",0.255491299044787,0.364597903619073,0.249796699946392,"MAPK14",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/37","23/2914",0.255491299044787,0.364597903619073,0.249796699946392,"STAT1",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/37","24/2914",0.265019774290495,0.370288952928532,0.253695804473938,"STAT1",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/37","24/2914",0.265019774290495,0.370288952928532,0.253695804473938,"TP53",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/37","24/2914",0.265019774290495,0.370288952928532,0.253695804473938,"TP53",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/37","24/2914",0.265019774290495,0.370288952928532,0.253695804473938,"STAT1",1
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","1/37","24/2914",0.265019774290495,0.370288952928532,0.253695804473938,"AKT2",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/37","24/2914",0.265019774290495,0.370288952928532,0.253695804473938,"STAT1",1
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/37","25/2914",0.274429555726914,0.374306979069703,0.256448671839329,"PRKACA",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/37","25/2914",0.274429555726914,0.374306979069703,0.256448671839329,"PRKACA",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/37","25/2914",0.274429555726914,0.374306979069703,0.256448671839329,"PRKACA",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/37","25/2914",0.274429555726914,0.374306979069703,0.256448671839329,"PRKACA",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/37","25/2914",0.274429555726914,0.374306979069703,0.256448671839329,"AKT2",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/37","25/2914",0.274429555726914,0.374306979069703,0.256448671839329,"MYC",1
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","1/37","25/2914",0.274429555726914,0.374306979069703,0.256448671839329,"AKT2",1
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","1/37","26/2914",0.283722081319889,0.383072574442005,0.262454237903566,"AKT2",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/37","26/2914",0.283722081319889,0.383072574442005,0.262454237903566,"PRKACA",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/37","26/2914",0.283722081319889,0.383072574442005,0.262454237903566,"PRKACA",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/37","27/2914",0.292898772106304,0.386356603995486,0.264704222713799,"YAP1",1
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/37","27/2914",0.292898772106304,0.386356603995486,0.264704222713799,"AKT2",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/37","27/2914",0.292898772106304,0.386356603995486,0.264704222713799,"PRKACA",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/37","27/2914",0.292898772106304,0.386356603995486,0.264704222713799,"PRKACA",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/37","27/2914",0.292898772106304,0.386356603995486,0.264704222713799,"JUN",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/37","27/2914",0.292898772106304,0.386356603995486,0.264704222713799,"JUN",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/37","27/2914",0.292898772106304,0.386356603995486,0.264704222713799,"TP53",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/37","28/2914",0.301961032387588,0.391614446102687,0.268306524301881,"SMAD3",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/37","28/2914",0.301961032387588,0.391614446102687,0.268306524301881,"PRKACA",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/37","28/2914",0.301961032387588,0.391614446102687,0.268306524301881,"VDR",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/37","28/2914",0.301961032387588,0.391614446102687,0.268306524301881,"PRKACA",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/37","28/2914",0.301961032387588,0.391614446102687,0.268306524301881,"VDR",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","5/37","289/2914",0.302744334892352,0.391614446102687,0.268306524301881,"ARNTL/CSNK2A1/PRKACA/CLOCK/VDR",5
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","3/37","153/2914",0.3071258159441,0.396004669432746,0.271314394860078,"MAPK1/MAPK14/MAPK3",3
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/37","29/2914",0.31091024992108,0.399599391725491,0.273777244363704,"STAT1",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/37","30/2914",0.319747796109267,0.40447591873759,0.27711829581444,"CSNK2A1",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/37","30/2914",0.319747796109267,0.40447591873759,0.27711829581444,"PRKACA",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/37","30/2914",0.319747796109267,0.40447591873759,0.27711829581444,"GSK3B",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/37","30/2914",0.319747796109267,0.40447591873759,0.27711829581444,"TP53",1
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","1/37","30/2914",0.319747796109267,0.40447591873759,0.27711829581444,"TP53",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","2/37","92/2914",0.327113262955608,0.409063619568186,0.280261463990803,"MAPK1/MAPK3",2
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/37","31/2914",0.328475026186922,0.409063619568186,0.280261463990803,"PRKACA",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/37","31/2914",0.328475026186922,0.409063619568186,0.280261463990803,"AKT2",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/37","31/2914",0.328475026186922,0.409063619568186,0.280261463990803,"MAPK14",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/37","31/2914",0.328475026186922,0.409063619568186,0.280261463990803,"STAT1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/37","32/2914",0.337093279406167,0.417204953832942,0.28583933049061,"STAT1",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/37","32/2914",0.337093279406167,0.417204953832942,0.28583933049061,"PRKACA",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/37","33/2914",0.345603879219481,0.426422017129268,0.292154210449505,"MAPK14",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/37","97/2914",0.350631291026469,0.431297999084706,0.295494888465962,"MAPK3/STAT1",2
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/37","34/2914",0.354008133460675,0.432796529017472,0.29652157520294,"CLOCK",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/37","34/2914",0.354008133460675,0.432796529017472,0.29652157520294,"TP53",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/37","35/2914",0.362307334523854,0.43892822097905,0.300722576914377,"MAPK14",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/37","35/2914",0.362307334523854,0.43892822097905,0.300722576914377,"PRKACA",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/37","35/2914",0.362307334523854,0.43892822097905,0.300722576914377,"TP53",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/37","37/2914",0.378595670553946,0.454541508659079,0.311419697493161,"GSK3B",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/37","37/2914",0.378595670553946,0.454541508659079,0.311419697493161,"PRKACA",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/37","37/2914",0.378595670553946,0.454541508659079,0.311419697493161,"STAT1",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/37","38/2914",0.386587314693503,0.462750785648044,0.317044113542826,"GSK3B",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","2/37","107/2914",0.396859631243674,0.473633071811647,0.324499886449245,"TP53/VDR",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/37","40/2914",0.402271717318179,0.475843535824748,0.326014340071556,"MYC",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/37","40/2914",0.402271717318179,0.475843535824748,0.326014340071556,"TCF7L2",1
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","1/37","40/2914",0.402271717318179,0.475843535824748,0.326014340071556,"SMAD3",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","2/37","109/2914",0.405945655881506,0.478777082377894,0.328024198715397,"TP53/VDR",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/37","41/2914",0.409966897018675,0.480692180422482,0.329336288463756,"STAT1",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/37","41/2914",0.409966897018675,0.480692180422482,0.329336288463756,"STAT1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/37","42/2914",0.417565652608758,0.482547050997441,0.330607114609088,"AKT2",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/37","42/2914",0.417565652608758,0.482547050997441,0.330607114609088,"TCF7L2",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/37","42/2914",0.417565652608758,0.482547050997441,0.330607114609088,"MAPK14",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/37","42/2914",0.417565652608758,0.482547050997441,0.330607114609088,"PRKACA",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/37","42/2914",0.417565652608758,0.482547050997441,0.330607114609088,"STAT1",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","3/37","188/2914",0.430824066663615,0.494085212907138,0.338512247194548,"AKT2/MAPK1/MAPK3",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/37","44/2914",0.432478577881311,0.494085212907138,0.338512247194548,"AKT2",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/37","44/2914",0.432478577881311,0.494085212907138,0.338512247194548,"YAP1",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/37","44/2914",0.432478577881311,0.494085212907138,0.338512247194548,"PRKACA",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/37","45/2914",0.439795056145559,0.498185925181834,0.341321765251237,"STAT1",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/37","45/2914",0.439795056145559,0.498185925181834,0.341321765251237,"PRKACA",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/37","45/2914",0.439795056145559,0.498185925181834,0.341321765251237,"PRKACA",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/37","46/2914",0.447019727781186,0.503525030450156,0.344979742610555,"AKT2",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/37","46/2914",0.447019727781186,0.503525030450156,0.344979742610555,"TP53",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/37","47/2914",0.454153713161973,0.510127840274373,0.349503520964985,"STAT1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/37","48/2914",0.46119811937509,0.516593424216232,0.353933281849157,"MAPK14",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/37","49/2914",0.468154040374085,0.522924150947098,0.358270648109181,"STAT1",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/37","50/2914",0.475022557130162,0.52501005394154,0.359699761330206,"AKT2",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/37","125/2914",0.476246196843998,0.52501005394154,0.359699761330206,"MAPK1/MAPK14",2
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/37","51/2914",0.481804737781762,0.52501005394154,0.359699761330206,"AKT2",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/37","51/2914",0.481804737781762,0.52501005394154,0.359699761330206,"AKT2",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","1/37","51/2914",0.481804737781762,0.52501005394154,0.359699761330206,"MYC",1
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","1/37","51/2914",0.481804737781762,0.52501005394154,0.359699761330206,"MYC",1
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","1/37","51/2914",0.481804737781762,0.52501005394154,0.359699761330206,"MYC",1
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","1/37","51/2914",0.481804737781762,0.52501005394154,0.359699761330206,"MYC",1
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","1/37","51/2914",0.481804737781762,0.52501005394154,0.359699761330206,"MYC",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/37","53/2914",0.495114300047354,0.535150496816682,0.366647275677002,"CSNK2A1",1
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","1/37","53/2914",0.495114300047354,0.535150496816682,0.366647275677002,"AKT2",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/37","53/2914",0.495114300047354,0.535150496816682,0.366647275677002,"PRKACA",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/37","55/2914",0.508091021202806,0.547700267479368,0.375245491041121,"PRKACA",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/37","61/2914",0.545104164807276,0.586023512299512,0.401501868250879,"CSNK2A1",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/37","62/2914",0.551003620083172,0.590781956292385,0.40476201756743,"TP53",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/37","64/2914",0.562580043291205,0.598422184846179,0.40999656187125,"MYC",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/37","64/2914",0.562580043291205,0.598422184846179,0.40999656187125,"PRKACA",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","3/37","228/2914",0.562606393234438,0.598422184846179,0.40999656187125,"MAPK1/MAPK14/MAPK3",3
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/37","76/2914",0.626178381567251,0.664279182562084,0.455117119434844,"TCF7L2",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/37","165/2914",0.629094748774651,0.665612122054446,0.456030355312273,"MAPK1/MAPK3",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","2/37","171/2914",0.648931543489388,0.684053108048463,0.468664814806796,"MAPK1/MAPK3",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","1/37","81/2914",0.649935746051034,0.684053108048463,0.468664814806796,"TP53",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","1/37","82/2914",0.654507711245567,0.68706175971066,0.47072613016008,"SMAD3",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","2/37","177/2914",0.667955325615186,0.699347481910417,0.479143438190363,"MAPK1/MAPK3",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","4/37","393/2914",0.755521534757446,0.785595995088651,0.538234820102738,"SMAD3/TP53/VDR/MYC",4
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","1/37","109/2914",0.758168703489546,0.785595995088651,0.538234820102738,"CLOCK",1
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","1/37","109/2914",0.758168703489546,0.785595995088651,0.538234820102738,"CLOCK",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/37","109/2914",0.758168703489546,0.785595995088651,0.538234820102738,"MAPK14",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","1/37","114/2914",0.773713895136291,0.798813612573968,0.54729059688097,"TP53",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/37","217/2914",0.77490896581365,0.798813612573968,0.54729059688097,"MAPK1/PRKACA",2
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/37","121/2914",0.793854349623012,0.816245113330327,0.559233428479369,"PRKACA",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","4/37","436/2914",0.826536276957792,0.847675312174104,0.580767178048146,"AKT2/MAPK1/MAPK3/PRKACA",4
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","1/37","144/2914",0.848492707542777,0.867973407460851,0.5946739974991,"AKT2",1
"R-HSA-73894","R-HSA-73894","DNA Repair","1/37","157/2914",0.872841415179944,0.890609179356635,0.610182427646887,"TP53",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","1/37","160/2914",0.877894375990264,0.893491484193136,0.612157179090192,"AKT2",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","4/37","486/2914",0.887601353143902,0.901083905343557,0.617358969142061,"AKT2/MAPK1/MAPK3/PRKACA",4
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","2/37","296/2914",0.902968912658056,0.914370035292628,0.626461685815398,"AKT2/PRKACA",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","0/37","20/2914",1,1,0.685129282058013,"",0
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","0/37","14/2914",1,1,0.685129282058013,"",0
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","0/37","11/2914",1,1,0.685129282058013,"",0
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","0/37","14/2914",1,1,0.685129282058013,"",0
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","0/37","29/2914",1,1,0.685129282058013,"",0
